Mark P. Okamoto
Impact in
- Family Practice top 1%
- Medication Adherence and Compliance
- Geriatrics and Gerontology top 1%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Medication Adherence and Compliance 5
-
- Pharmaceutical Practices and Patient Outcomes 8
- Co-authors
- Alfred ChinDavid A. SclarMark A. GillTracy L. SkaerAnandi V. LawAshley ChinRandy NakahiroDonald Hsu
- Journals
- American Journal of Health-System Pharmacy (4 papers)Therapeutic Drug Monitoring (3 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)The American Journal of Medicine (2 papers)
- Partner nations
- United StatesJapan
In The Last Decade
Mark P. Okamoto
28 papers receiving 759 citations
Peers
Comparison fields: 5 of 96
- Family Practice 161
- Geriatrics and Gerontology 223
- Applied Microbiology and Biotechnology 90
- Molecular Medicine 168
- Pharmacology 251
Countries citing papers authored by Mark P. Okamoto
This map shows the geographic impact of Mark P. Okamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark P. Okamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark P. Okamoto more than expected).
Fields of papers citing papers by Mark P. Okamoto
This network shows the impact of papers produced by Mark P. Okamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark P. Okamoto. The network helps show where Mark P. Okamoto may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark P. Okamoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 51 | |
| 2 | 2008 | 39 | |
| 3 | 2007 | 14 | |
| 4 | 2007 | 11 | |
| 5 | 2005 | 69 | |
| 6 | 2005 | 20 | |
| 7 | 2003 | 23 | |
| 8 | 2001 | 80 | |
| 9 | 1994 | 16 | |
| 10 | 1994 | 59 | |
| 11 | Effect of pharmaceutical formulation for antihypertensive therapy on health service utilization. | 1993 | 16 |
| 12 | 1993 | 53 | |
| 13 | 1993 | 5 | |
| 14 | 1992 | 15 | |
| 15 | 1992 | 11 | |
| 16 | 1992 | 49 | |
| 17 | 1991 | 13 | |
| 18 | 1991 | 35 | |
| 19 | Effect of health education in promoting prescription refill compliance among patients with hypertension. | 1991 | 97 |
| 20 | 1990 | 7 |
About Mark P. Okamoto
Mark P. Okamoto is a scholar working on Family Practice, Geriatrics and Gerontology, Applied Microbiology and Biotechnology, Molecular Medicine and Pharmacology, having authored 28 papers that have together received 818 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Pharmaceutical Practices and Patient Outcomes (8 papers), Antibiotic Resistance in Bacteria (6 papers), Medication Adherence and Compliance (5 papers), Pneumonia and Respiratory Infections (4 papers), Antibiotic Use and Resistance (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Gallbladder and Bile Duct Disorders (4 papers). The work is most often cited by research in Family Practice (161 citations), Geriatrics and Gerontology (223 citations), Applied Microbiology and Biotechnology (90 citations), Molecular Medicine (168 citations) and Pharmacology (251 citations). Mark P. Okamoto has collaborated with scholars based in United States and Japan. Frequent co-authors include Alfred Chin, David A. Sclar, Mark A. Gill, Tracy L. Skaer, Anandi V. Law, Ashley Chin, Randy Nakahiro, Donald Hsu, Annie Wong‐Beringer and Rekha Murthy. Their work appears in journals such as American Journal of Health-System Pharmacy, Therapeutic Drug Monitoring, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Antimicrobial Agents and Chemotherapy and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.